公开(公告)号：WO2020250033A1

公开(公告)日：2020-12-17

申请号：PCT/IB2020/000443

申请日：2020-06-09

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： PALUMBO, Antonio ,  ALLIKMETS, Kristina ,  BERG, Deborah ,  FEDYK, Eric

IPC: A61K39/395 ,  C07K16/28 ,  A61K31/573

Abstract: Methods of administering isolated anti-CD38 antibodies in combination with lenalidomide or pomobdomide, and dexamethasone and, optionally, bortezomib, for the treatment of multiple myeloma.

公开(公告)号：EP3980064A1

公开(公告)日：2022-04-13

申请号：EP20737529.6

申请日：2020-06-09

Applicant: Takeda Pharmaceutical Company Limited

Inventor： PALUMBO, Antonio ,  ALLIKMETS, Kristina ,  BERG, Deborah ,  FEDYK, Eric

IPC: A61K39/395 ,  C07K16/28 ,  A61K31/573